Li, X., Li, C., Cheng, Y., Zhang, B., Xu, Y. (2025). A phase 2, randomized, multicenter study of adjuvant adebrelimab plus capecitabine in resected cholangiocarcinoma with high-risk factors: ACHIEVE.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps4220